Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
2021
Distributor bribed 1.8 million yuan for CT contract amid multiple bribery cases
During Neusoft Medical's Hong Kong IPO hearing in 2021, media reviewed court judgments and found that its Ganzi Prefecture agent bribed 1.8 million yuan for an 8.97 million yuan CT bid win; in nearly six years, there were nearly 10 bribery cases involving Neusoft CT and other equipment, totaling more than 13 million yuan, with bribe payers mostly distributors. Neusoft Medical itself was not penalized, but its sales compliance was questioned.